SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105134 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Karolina Buchholz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszc…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biomarkers, Tumor, Carcinoma, Pancreatic Ductal, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nicolaus Copernicus University.
Abstract (Originalsprache)
The spindle and kinetochore-associated complex subunit 3 (SKA3) is a protein essential for proper chromosome segregation during mitosis and thus responsible for maintaining genome stability. Although its involvement in the pathogenesis of various cancer types has been reported, the potential clinicopathological significance of SKA3 in pancreatic ductal adenocarcinoma (PDAC) has not been fully elucidated. Therefore, this study aimed to assess clinicopathological associations and prognostic value of SKA3 in PDAC. For this purpose, in-house immunohistochemical analysis on tissue macroarrays (TMAs), as well as a bioinformatic examination using publicly available RNA-Seq dataset, were performed. It was demonstrated that SKA3 expression at both mRNA and protein levels was significantly elevated in PDAC compared to control tissues. Upregulated mRNA expression constituted an independent unfavorable prognostic factor for the overall survival of PDAC patients, whereas altered SKA3 protein levels were associated with significantly better clinical outcomes. The last observation was particularly clear in the early-stage tumors. These findings render SKA3 a promising prognostic biomarker for patients with pancreatic ductal adenocarcinoma. However, further studies are needed to confirm this conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland.
- Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-092 Bydgoszcz, Poland.
- Department of Oncology and Brachytherapy, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-796 Bydgoszcz, Poland.
- Clinical Department of Oncology, Professor Franciszek Lukaszczyk Oncology Center in Bydgoszcz, 85-796 Bydgoszcz, Poland.
- Department of General, Hepatobiliary and Transplant Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland.
ORCID-Profile: Karolina Buchholz, Justyna Durślewicz, Anna Klimaszewska-Wiśniewska, Dariusz Grzanka
Förderung
- Nicolaus Copernicus University
Zitieren
APA
Buchholz, K., Durślewicz, J., Klimaszewska-Wiśniewska, A., Wiśniewska, M., Słupski, M., & Grzanka, D. (2024). SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105134
Vancouver
Buchholz K, Durślewicz J, Klimaszewska-Wiśniewska A, Wiśniewska M, Słupski M, Grzanka D. SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105134
BibTeX
@article{Buchholz2024,
author = {Buchholz, Karolina and Durślewicz, Justyna and Klimaszewska-Wiśniewska, Anna and Wiśniewska, Magdalena and Słupski, Maciej and Grzanka, Dariusz},
title = {SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105134}
}
EUVIMED